Assessment of serum bile acid profiles as biomarkers of liver injury and liver disease in humans
Fig 3
Serum bile acid composition changes among healthy, hepatic injury, and drug-induced liver injury (DILI) subjects.
(A) Bile acid pattern comparisons between healthy and hepatic injury subjects demonstrated differences between the two groups. (B) Slight differences in the bile acid patterns of APAP overdosed patients (DILI) and all hepatic injury subjects were observed. Numbers were expressed as a percent of the total individual bile acids measured.